Orange, CA 的 重度憂鬱症 臨床試驗
13 項針對 重度憂鬱症 的研究正在 Orange（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
招募中2 期
- PNS Clinical Research LLC dba ATP Clinical Research, Orange
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
招募中3 期
- ATP Clinical Research, Orange
- NRC Research Institute, Orange
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
招募中3 期
- ATP Clinical Research Orange County, Orange
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
招募中3 期
- ATP Clinical Research, Orange
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
招募中3 期
- NRC Research Institute, Orange
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
招募中2 期
- Nrc Research Institute, Orange
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
招募中3 期
- Vanda Investigational Site, Orange
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
招募中4 期
- Neurocrine Clinical Site, Orange
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
招募中3 期
- Atp Clinical Research, Orange
- Nrc Research Institute, Orange
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Orange
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Orange
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
招募中2 期
- Autobahn Site #152, Orange
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Orange
其他城市的 重度憂鬱症 試驗
- New York City, NY36 項研究
- Boston, MA31 項研究
- Atlanta, GA25 項研究
- Philadelphia, PA23 項研究
- Orlando, FL19 項研究
- Miami, FL18 項研究
- Chicago, IL17 項研究
- Tampa, FL17 項研究
- Houston, TX16 項研究
- San Diego, CA16 項研究
- Little Rock, AR14 項研究
- Austin, TX13 項研究
Orange 的其他研究
- 非小細胞肺癌25 項研究
- 轉移性癌症20 項研究
- 大腸直腸癌16 項研究
- 卵巢癌16 項研究
- 胰臟癌15 項研究
- 黑色素瘤14 項研究
- 肝癌（肝細胞癌）14 項研究
- 乳癌14 項研究
- 肺癌14 項研究
- 前列腺癌14 項研究
- 胃癌13 項研究
- 癌症（所有類型）13 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。